Want to see HK:2898 full AI Analyst Report?
Sunho Biologics,Inc. (2898) Financial Statements
Sunho Biologics,Inc. Financial Overview
Sunho Biologics,Inc.'s market cap is currently $970.43M. The company's EPS TTM is $-0.54; its P/E ratio is -8.74; Sunho Biologics,Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 38.00K | $ 17.53M | $ 1.73M | $ 3.22M |
| Gross Profit | $ 38.00K | $ 138.00K | $ 473.00K | $ 3.22M |
| Operating Income | $ -101.36M | $ -66.21M | $ -56.88M | $ -66.62M |
| EBITDA | $ -91.92M | $ -123.37M | $ -38.11M | $ -60.53M |
| Net Income | $ -79.97M | $ -132.70M | $ -51.99M | $ -70.63M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 457.28M | $ 210.07M | $ 1.82M | $ 10.66M |
| Total Assets | $ 560.74M | $ 290.45M | $ 70.86M | $ 84.95M |
| Total Debt | $ 41.20M | $ 9.07M | $ 11.03M | $ 160.86M |
| Net Debt | $ -37.80M | $ -116.00M | $ -1.82M | $ 147.74M |
| Total Liabilities | $ 48.80M | $ 394.56M | $ 72.36M | $ 216.50M |
| Stockholders' Equity | $ 511.94M | $ -104.11M | $ -1.50M | $ -131.55M |
| Cash Flow | ||||
| Free Cash Flow | $ -158.28M | $ -41.68M | $ -36.02M | $ -58.17M |
| Operating Cash Flow | $ -109.02M | $ -40.65M | $ -34.59M | $ -52.65M |
| Investing Cash Flow | $ -345.04M | $ -83.89M | $ -1.36M | $ -10.36M |
| Financing Cash Flow | $ 406.53M | $ 255.50M | $ 27.10M | $ 64.98M |
Currency in CNY